| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 24, 2026Virtual Press Office and PR Newswire: General Trade show news
KTX-2001 is being evaluated in the Phase 1 STRIKE-001 clinical trial both as a monotherapy and in combination with darolutamide in metastatic castration-resistant prostate cancer (mCRPC)...
-
Feb 24, 2026Virtual Press Office and PR Newswire: General Trade show news
Previously unpublished clinical data support the potential long‑term safety and efficacy of collagenase clostridium histolyticum (CCH) for plantar fibromatosis. The findings will be presented at...
-
Feb 24, 2026Virtual Press Office and PR Newswire: General Trade show news
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...
-
Feb 24, 2026Virtual Press Office and PR Newswire: General Trade show news
The Quaint Quant Conference—the South's only dedicated quantitative finance event—returns on Friday, April 10, 2026, hosted at the SMU Cox School of Business in Dallas. Now in its fourth year,...
-
Feb 24, 2026Virtual Press Office and PR Newswire: General Trade show news
Dr. Christine N. Kay to Present Multivariant Analysis of 3-Year RESTORE and REMAIN Data, Identifying Patient and Disease Characteristics Associated with Best Outcomes in Retinitis Pigmentosa...
